News
A guideline has recommended two key drugs be prescribed in all patients with type 2 diabetes who are at higher risk.
In 2025, Släcka introduces a functional beverage designed to combat mid-afternoon cravings by offering a healthier ...
GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that regulate blood sugar, appetite, and digestion. GLP-1 (glucagon-like ...
8h
News-Medical.Net on MSNGIPR signaling opens brain’s gate for GLP-1 weight-loss therapy
A Cell Metabolism study reveals that GIPR signaling in oligodendrocytes enhances brain access and weight-loss efficacy of GLP ...
11h
Everyday Health on MSNFDA Raises Safety Concerns About Compounded GLP-1 Weight Loss Drugs
The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...
Insurance companies are increasingly restricting coverage for GLP-1 medications, impacting patient access and affordability.
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...
GLP-1 weight-loss drugs have already taken the Europe storm, altering consumer eating habits. Even the eating habits of GLP-1 ...
Weight-loss drugs like Mounjaro and Ozempic work wonders on your waistline but can cause chaos with your scalp. Here’s what ...
The company is also focused on strategic capital deployment. It has already invested in GLP-1 drug substance and drug product ...
The two GLP-1 makers have also begun to offer discounts to users who pay in cash directly. These programs, which cost about $500 per month, may require the use of a vial and syringe, as opposed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results